| William Michael Lyth, MD | |
|
618 Hospital Rd, Tappahannock, VA 22560-5000 | |
| (804) 443-3311 | |
| (804) 443-6150 |
| Full Name | William Michael Lyth |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 618 Hospital Rd, Tappahannock, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225031263 | NPI | - | NPPES |
| 1225031263 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 01010444027 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William Michael Lyth, MD 856 J Clyde Morris Blvd, Suite A, Newport News, VA 23601-1318 Ph: (757) 594-4006 | William Michael Lyth, MD 618 Hospital Rd, Tappahannock, VA 22560-5000 Ph: (804) 443-3311 |
News Archive
A medical device that has been shown to manage pain among babies born preterm can also help keep their brain oxygen levels steady during medical procedures, finds new analysis by researchers at UBC.
Taking gold nanoparticles to the cancer cell and hitting them with a laser has been shown to be a promising tool in fighting cancer, but what about cancers that occur in places where a laser light can't reach? Scientists at the Georgia Institute of Technology have shown that by directing gold nanoparticles into the nuclei of cancer cells, they can not only prevent them from multiplying, but can kill them where they lurk. The research appeared as a communication in the February 10 edition of the Journal of the American Chemical Society.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz Tablets, 50 mg, 100 mg and 200 mg. These innovative pediatric dosages in tablet form were developed by Matrix for use in treating pediatric HIV/AIDS.
Gilead Sciences, Inc. today announced that the company's Board of Directors has authorized the repurchase of up to $5 billion of the company's common stock through May 2013.
In this post in PSI's "Healthy Lives" blog, Deputy Editor Tom Murphy examines routine vaccination solutions in Nigeria, where "the Decade of Vaccines Economics projects 90 percent vaccine coverage against Hib, pneumococcal disease, rotavirus, measles and pertussis can save 600,000 lives and $17 billion in Nigeria over the next 10 years."
› Verified 9 days ago
Miss Bonnie Deschner, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 618 Hospital Rd, Riverside Tappahannock Hospital, Tappahannock, VA 22560 Phone: 804-443-3311 | |
Conceicao Maria Berkowitz, CRNA Anesthesiology Medicare: Medicare Enrolled Practice Location: 618 Hospital Rd, Tappahannock, VA 22560 Phone: 804-443-3311 | |
Dr. Alan M Bolash, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 659 Hospital Rd, 101, Tappahannock, VA 22560 Phone: 804-433-6020 |